Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, BridgeBio Pharma Inc’s stock clocked out at $35.96, up 2.07% from its previous closing price of $35.23. In other words, the price has increased by $2.07 from its previous closing price. On the day, 1.54 million shares were traded. BBIO stock price reached its highest trading level at $35.989 during the session, while it also had its lowest trading level at $34.71.
Ratios:
To gain a deeper understanding of BBIO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.67 and its Current Ratio is at 4.67.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Redburn Atlantic on March 31, 2025, initiated with a Buy rating and assigned the stock a target price of $50.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 22 ’25 when Kumar Neil sold 75,000 shares for $34.11 per share. The transaction valued at 2,558,025 led to the insider holds 4,873,447 shares of the business.
Ellis Andrea sold 10,000 shares of BBIO for $350,000 on Apr 14 ’25. The Director now owns 12,000 shares after completing the transaction at $35.00 per share. On Apr 14 ’25, another insider, ANDREA ELLIS, who serves as the Director of the company, bought 10,000 shares for $35.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BBIO now has a Market Capitalization of 6839196160 and an Enterprise Value of 7898957824. For the stock, the TTM Price-to-Sale (P/S) ratio is 30.77. Its current Enterprise Value per Revenue stands at 35.597 whereas that against EBITDA is -14.238.
Stock Price History:
The Beta on a monthly basis for BBIO is 1.14, which has changed by 0.44533765 over the last 52 weeks, in comparison to a change of 0.07545352 over the same period for the S&P500. Over the past 52 weeks, BBIO has reached a high of $39.47, while it has fallen to a 52-week low of $21.62. The 50-Day Moving Average of the stock is 5.99%, while the 200-Day Moving Average is calculated to be 24.02%.
Shares Statistics:
It appears that BBIO traded 2.96M shares on average per day over the past three months and 2107010 shares per day over the past ten days. A total of 190.04M shares are outstanding, with a floating share count of 155.16M. Insiders hold about 18.28% of the company’s shares, while institutions hold 76.79% stake in the company. Shares short for BBIO as of 1743379200 were 21707824 with a Short Ratio of 7.34, compared to 1740700800 on 22155112. Therefore, it implies a Short% of Shares Outstanding of 21707824 and a Short% of Float of 17.459999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
